| Literature DB >> 22312510 |
Raoul Quarati1, Massimo Summa, Fabio Priora, Valeria Maglione, Ferruccio Ravazzoni, Luca Matteo Lenti, Graziella Marino, Federica Grosso, Giuseppe Spinoglio.
Abstract
Laparoscopic colon resection has established its role as a minimally invasive approach to colorectal diseases. Better long-term survival rate is suggested to be achievable with this approach in colon cancer patients, whereas some doubts were raised about its safety in rectal cancer. Here we report on our single centre experience of rectal laparoscopic resections for cancer focusing on short- and long-term oncological outcomes. In the last 13 years, 248 patients underwent minimally invasive approach for rectal cancer at our centre. We focused on 99 stage I, II, and III patients with a minimum follow-up period of 5 years. Of them 43 had a middle and 56 lower rectal tumor. Laparoscopic anterior rectal resection was performed in 71 patients whereas laparoscopic abdomino-perineal resection in 28. The overall mortality rate was 1%; the overall morbidity rate was 29%. The 5-year disease-free survival rate was 69.7%, The 5-year overall survival rate was 78.8%.Entities:
Year: 2011 PMID: 22312510 PMCID: PMC3263684 DOI: 10.1155/2011/473614
Source DB: PubMed Journal: Int J Surg Oncol ISSN: 2090-1402
Patients characteristics.
| Characteristic | Middle tumor ( | Lower tumor ( |
|---|---|---|
| Mean age (range) | 71 (42–96) | 70 (42–91) |
|
| ||
| Gender | ||
| Males | 25 | 34 |
| Females | 18 | 22 |
|
| ||
| Stage TNM | ||
| I | 8 (17%) | 5 (42%) |
| II | 13 (50%) | 24 (30%) |
| III | 22 (33%) | 27 (28%) |
Complications.
| Complications | No. of patient (%) |
|---|---|
| Urinary retention | 8 (8%) |
| Anastomotic bleeding | 5 (7%) |
| Wound infection | 3 (3%) |
| Anastomotic leakage | 3 (4,2%) |
| Small bowel obstruction | 2 (2%) |
Local and distant recurrence.
| Site of recurrence |
|
|---|---|
| Lung | 13 (48%) |
| Liver | 7 (25%) |
| Local | 3 (11%) |
| Lymph nodes | 2 (7%) |
| Peritoneum | 1 (3%) |
| Brain | 1 (3%) |
Figure 1Overall survival.
Figure 2Disease-free survival.
Figure 3Overall survival stratified per stage.
Figure 4Disease-free survival stratified per stage.